📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19. (2022)

First Author: Lynch NJ

Attributed to: HICC: Humoral Immune Correlates for COVID19: Defining protective responses and critical readouts for Clinical Trials of Vaccines and Therapeutics funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ctm2.980

PubMed Identifier: 35839316

Publication URI: http://europepmc.org/abstract/MED/35839316

Type: Journal Article/Review

Volume: 12

Parent Publication: Clinical and translational medicine

Issue: 7

ISSN: 2001-1326